Profil
Kelly O’Brien Wilson currently works at Forte Animal Health, Inc., as Director from 2020 and Biostax Corp., as Chief Operating Officer from 2022.
Ms. Wilson also formerly worked at Biostax Corp., as CTO & Director-Human Resources from 2015 to 2020, Biostax Corp., as Chief Executive & Operating Officer in 2023, and Cytocom, Inc., as Chief Technology & Information Officer from 2016 to 2020.
Ms. Wilson received her undergraduate degree and graduate degree from the University of Central Florida.
Aktiva positioner av Kelly Wilson
| Företag | Position | Start |
|---|---|---|
| BIOSTAXPAR | Verksamhetschef | 2022-08-01 |
Forte Animal Health, Inc. | Direktör/Styrelseledamot | 2020-12-01 |
Tidigare kända positioner av Kelly Wilson
| Företag | Position | Slut |
|---|---|---|
| BIOSTAXPAR | Verkställande Direktör | 2023-07-25 |
| BIOSTAXPAR | Teknisk/Vetenskaplig/F&U Direktör | 2020-04-01 |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Teknisk/Vetenskaplig/F&U Direktör | 2020-04-01 |
Kelly Wilsons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Central Florida
University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biostax Corp.
Biostax Corp. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical & biotechnology products | Health Technology |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
Forte Animal Health, Inc. | Process Industries |
















